Kewalramani Reshma
Insider CIK 1735944 · DNA Director · VRTX EVP and CMO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-27 | 2026-03-03 | 15,580 | $495.38 | $7.72M | 105,998 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-27 | 2026-03-03 | 3,498 | $494.33 | $1.73M | 121,578 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-27 | 2026-03-03 | 2,520 | $493.29 | $1.24M | 125,076 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-27 | 2026-03-03 | 949 | $491.30 | $466.2K | 127,596 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-27 | 2026-03-03 | 2,725 | $490.54 | $1.34M | 128,545 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-27 | 2026-03-03 | 5,995 | $496.16 | $2.97M | 100,003 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-27 | 2026-03-03 | 1,725 | $496.95 | $857.2K | 98,278 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-27 | 2026-03-03 | 460 | $489.32 | $225.1K | 131,270 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-27 | 2026-03-03 | 400 | $479.75 | $191.9K | 137,878 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-27 | 2026-03-03 | 120 | $481.50 | $57.8K | 137,758 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-27 | 2026-03-03 | 240 | $482.84 | $115.9K | 137,518 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-27 | 2026-03-03 | 2,510 | $487.13 | $1.22M | 135,008 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-27 | 2026-03-03 | 3,278 | $488.27 | $1.60M | 131,730 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-24 | 2026-02-26 | 4,981 | $485.11 | $2.42M | 138,278 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-17 | 2026-02-19 | 6,554 | $483.75 | $3.17M | 143,259 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-02-17 | 2026-02-19 | 16,326 | — | $0 | 149,813 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-13 | 2026-02-18 | 13,041 | $487.76 | $6.36M | 133,487 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-10 | 2026-02-12 | 8,297 | $468.41 | $3.89M | 146,528 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-01-22 | 2026-01-26 | 11,885 | — | $0 | 154,825 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-01-22 | 2026-01-26 | 26,972 | — | $0 | 142,940 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | P Buy | 2025-08-06 | 2025-08-07 | 5,710 | $389.95 | $2.23M | 115,968 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | P Buy | 2025-08-06 | 2025-08-07 | 4,290 | $389.08 | $1.67M | 110,258 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-26 | 2025-02-28 | 14,079 | $479.61 | $6.75M | 105,915 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-24 | 2025-02-26 | 9,386 | $483.28 | $4.54M | 119,994 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-14 | 2025-02-19 | 6,553 | $463.46 | $3.04M | 129,380 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2025-02-12 | 2025-02-14 | 19,015 | — | $0 | 135,933 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-10 | 2025-02-12 | 8,300 | $467.98 | $3.88M | 116,918 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2025-02-04 | 2025-02-06 | 20,328 | — | $0 | 125,218 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2025-02-04 | 2025-02-06 | 29,118 | — | $0 | 104,890 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-11-08 | 2024-11-12 | 15,198 | $515.00 | $7.83M | 75,772 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-07-30 | 2024-08-01 | 15,202 | $505.00 | $7.68M | 90,970 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-07-22 | 2024-07-24 | 15,202 | $497.00 | $7.56M | 106,172 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | M Exercise deriv | 2024-06-12 | 2024-06-14 | 105,263 | — | $0 | 0 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | M Exercise | 2024-06-12 | 2024-06-14 | 105,263 | — | $0 | 186,002 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2024-05-24 | 2024-05-29 | 1,565 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2024-05-24 | 2024-05-29 | 1,565 | $187.53 | $293.5K | 122,939 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-05-24 | 2024-05-29 | 1,565 | $457.00 | $715.2K | 121,374 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-05-20 | 2024-05-22 | 15,202 | $447.00 | $6.80M | 121,374 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-02-23 | 2024-02-27 | 9,386 | $431.79 | $4.05M | 136,507 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-02-20 | 2024-02-21 | 7,019 | $420.58 | $2.95M | 145,893 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-02-16 | 2024-02-21 | 9,359 | $424.01 | $3.97M | 152,912 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-02-09 | 2024-02-13 | 8,255 | $422.74 | $3.49M | 162,271 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2024-02-07 | 2024-02-08 | 20,327 | — | $0 | 170,526 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2024-02-06 | 2024-02-08 | 14,516 | — | $0 | 123,227 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2024-02-06 | 2024-02-08 | 26,972 | — | $0 | 150,199 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2023-12-15 | 2023-12-19 | 14,077 | — | $0 | 1,565 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2023-12-15 | 2023-12-19 | 3,058 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2023-12-15 | 2023-12-19 | 3,058 | $155.57 | $475.7K | 111,769 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-12-15 | 2023-12-19 | 17,135 | $407.00 | $6.97M | 108,711 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2023-12-15 | 2023-12-19 | 14,077 | $187.53 | $2.64M | 125,846 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-12-13 | 2023-12-15 | 5,098 | $397.00 | $2.02M | 108,711 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-11-13 | 2023-11-15 | 5,097 | $377.00 | $1.92M | 113,809 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-07-17 | 2023-07-18 | 7,828 | $355.00 | $2.78M | 118,906 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | A Award deriv | 2023-06-16 | 2023-06-21 | 139,860 | — | $0 | 139,860 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | A Award deriv | 2023-06-16 | 2023-06-21 | 105,263 | — | $0 | 105,263 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-04-27 | 2023-05-01 | 1,668 | $339.43 | $566.2K | 126,690 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-04-27 | 2023-05-01 | 1,611 | $338.69 | $545.6K | 128,358 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-04-27 | 2023-05-01 | 38 | $340.19 | $12.9K | 126,652 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2023-02-24 | 2023-02-28 | 9,386 | $289.12 | $2.71M | 129,969 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2023-02-17 | 2023-02-22 | 9,359 | $292.85 | $2.74M | 139,355 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2023-02-13 | 2023-02-14 | 5,990 | $298.26 | $1.79M | 148,714 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2023-02-10 | 2023-02-14 | 3,372 | $294.33 | $992.5K | 154,704 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2023-02-01 | 2023-02-03 | 12,388 | — | $0 | 101,986 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2023-02-01 | 2023-02-03 | 29,118 | — | $0 | 131,104 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2023-02-01 | 2023-02-03 | 26,972 | — | $0 | 158,076 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-01-25 | 2023-01-27 | 10,000 | $315.05 | $3.15M | 89,598 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | M Exercise deriv | 2022-09-30 | 2022-11-10 | 9,818 | — | $0 | 0 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | M Exercise | 2022-09-30 | 2022-11-10 | 9,818 | — | $0 | 80,739 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-08-15 | 2022-08-17 | 11,689 | $305.06 | $3.57M | 99,598 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-06-24 | 2022-06-28 | 11,689 | $291.30 | $3.41M | 111,153 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | A Award deriv | 2022-06-10 | 2022-06-13 | 108,516 | — | $0 | 108,516 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | A Award | 2022-06-10 | 2022-06-13 | 70,921 | — | $0 | 70,921 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2022-02-24 | 2022-02-28 | 7,246 | $227.86 | $1.65M | 122,842 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2022-02-17 | 2022-02-22 | 8,584 | $232.51 | $2.00M | 130,088 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2022-02-10 | 2022-02-14 | 3,031 | $237.74 | $720.6K | 138,672 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2022-02-01 | 2022-02-03 | 29,032 | — | $0 | 112,586 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2022-02-01 | 2022-02-03 | 29,117 | — | $0 | 141,703 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2022-02-01 | 2022-02-03 | 9,800 | — | $0 | 83,554 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | A Award deriv | 2021-11-19 | 2021-11-23 | 9,818 | — | $0 | 9,818 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | A Award deriv | 2021-09-16 | 2021-09-20 | 17,649 | — | $0 | 17,649 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | A Award deriv | 2021-09-16 | 2021-09-20 | 51,782 | — | $0 | 51,782 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | P Buy | 2021-08-19 | 2021-08-23 | 4,243 | $196.34 | $833.1K | 73,754 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | P Buy | 2021-08-19 | 2021-08-23 | 5,757 | $195.14 | $1.12M | 69,511 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2021-02-24 | 2021-02-26 | 2,898 | $217.57 | $630.5K | 63,643 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2021-02-17 | 2021-02-19 | 2,080 | $211.75 | $440.4K | 66,541 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2021-02-10 | 2021-02-12 | 2,962 | $214.16 | $634.3K | 68,621 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2021-02-03 | 2021-02-05 | 3,516 | — | $0 | 30,164 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2021-02-03 | 2021-02-05 | 29,031 | — | $0 | 71,583 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2021-02-03 | 2021-02-05 | 12,388 | — | $0 | 42,552 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2020-08-06 | 2020-08-10 | 509 | — | $0 | 3,058 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2020-08-06 | 2020-08-10 | 1,564 | — | $0 | 15,642 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2020-08-06 | 2020-08-10 | 1,564 | $187.53 | $293.3K | 28,190 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2020-08-06 | 2020-08-10 | 509 | $155.57 | $79.2K | 28,699 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-08-06 | 2020-08-10 | 152 | $269.11 | $40.9K | 28,547 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-08-06 | 2020-08-10 | 870 | $270.36 | $235.2K | 27,677 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-08-06 | 2020-08-10 | 471 | $271.42 | $127.8K | 27,206 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-08-06 | 2020-08-10 | 487 | $272.76 | $132.8K | 26,719 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-08-06 | 2020-08-10 | 93 | $273.27 | $25.4K | 26,626 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-15 | 2020-05-19 | 2 | $274.37 | $549 | 26,723 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-15 | 2020-05-19 | 6 | $276.40 | $1.7K | 26,717 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-15 | 2020-05-19 | 7 | $279.70 | $2.0K | 26,710 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-15 | 2020-05-19 | 9 | $280.47 | $2.5K | 26,701 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-15 | 2020-05-19 | 6 | $281.74 | $1.7K | 26,695 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-15 | 2020-05-19 | 9 | $288.37 | $2.6K | 26,626 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-15 | 2020-05-19 | 19 | $287.63 | $5.5K | 26,635 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-15 | 2020-05-19 | 27 | $286.07 | $7.7K | 26,654 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-15 | 2020-05-19 | 10 | $283.76 | $2.8K | 26,681 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-15 | 2020-05-19 | 4 | $282.74 | $1.1K | 26,691 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2020-05-06 | 2020-05-08 | 1,564 | — | $0 | 17,206 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2020-05-06 | 2020-05-08 | 510 | — | $0 | 3,567 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-06 | 2020-05-08 | 416 | $270.35 | $112.5K | 28,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2020-05-06 | 2020-05-08 | 1,564 | $187.53 | $293.3K | 28,190 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2020-05-06 | 2020-05-08 | 510 | $155.57 | $79.3K | 28,700 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-06 | 2020-05-08 | 300 | $271.92 | $81.6K | 27,984 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-06 | 2020-05-08 | 134 | $275.17 | $36.9K | 26,626 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-06 | 2020-05-08 | 864 | $274.04 | $236.8K | 26,760 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-05-06 | 2020-05-08 | 360 | $272.77 | $98.2K | 27,624 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-25 | 2020-02-26 | 420 | $238.28 | $100.1K | 26,737 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-25 | 2020-02-26 | 320 | $236.71 | $75.7K | 27,157 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-25 | 2020-02-26 | 340 | $235.36 | $80.0K | 27,477 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-25 | 2020-02-26 | 660 | $234.41 | $154.7K | 27,817 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-25 | 2020-02-26 | 450 | $230.88 | $103.9K | 28,917 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-25 | 2020-02-26 | 893 | $229.72 | $205.1K | 29,367 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-25 | 2020-02-26 | 111 | $239.13 | $26.5K | 26,626 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-25 | 2020-02-26 | 440 | $232.35 | $102.2K | 28,477 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2020-02-24 | 2020-02-26 | 2,898 | $239.23 | $693.3K | 30,260 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-18 | 2020-02-19 | 120 | $241.71 | $29.0K | 34,221 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-18 | 2020-02-19 | 540 | $242.62 | $131.0K | 33,681 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-18 | 2020-02-19 | 134 | $243.76 | $32.7K | 33,547 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-18 | 2020-02-19 | 260 | $244.94 | $63.7K | 33,287 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-18 | 2020-02-19 | 129 | $245.75 | $31.7K | 33,158 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2020-02-17 | 2020-02-19 | 944 | $241.50 | $228.0K | 34,341 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2020-02-06 | 2020-02-07 | 510 | — | $0 | 4,077 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2020-02-06 | 2020-02-07 | 1,564 | — | $0 | 18,770 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-06 | 2020-02-07 | 1,251 | $238.76 | $298.7K | 36,108 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2020-02-06 | 2020-02-07 | 1,564 | $187.53 | $293.3K | 36,849 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2020-02-06 | 2020-02-07 | 510 | $155.57 | $79.3K | 37,359 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-06 | 2020-02-07 | 423 | $239.69 | $101.4K | 35,685 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-06 | 2020-02-07 | 271 | $240.75 | $65.2K | 35,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2020-02-06 | 2020-02-07 | 129 | $242.47 | $31.3K | 35,285 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2020-02-05 | 2020-02-07 | 12,387 | — | $0 | 35,285 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2020-02-05 | 2020-02-07 | 9,800 | — | $0 | 22,898 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2019-11-25 | 2019-11-26 | 4,692 | — | $0 | 20,334 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-11-25 | 2019-11-26 | 4,692 | $219.37 | $1.03M | 13,098 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2019-11-25 | 2019-11-26 | 4,692 | $187.53 | $879.9K | 17,790 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-11-15 | 2019-11-19 | 61 | $205.95 | $12.6K | 13,098 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2019-11-08 | 2019-11-13 | 509 | — | $0 | 4,587 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2019-11-08 | 2019-11-13 | 509 | $155.57 | $79.2K | 13,607 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-11-08 | 2019-11-13 | 509 | $199.00 | $101.3K | 13,098 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2019-10-30 | 2019-10-31 | 3,057 | — | $0 | 5,096 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-10-30 | 2019-10-31 | 3,057 | $199.00 | $608.3K | 13,098 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2019-10-30 | 2019-10-31 | 3,057 | $155.57 | $475.6K | 16,155 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-10-22 | 2019-10-24 | 638 | $189.00 | $120.6K | 13,098 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-05-15 | 2019-05-17 | 241 | $165.41 | $39.9K | 13,736 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-02-19 | 2019-02-21 | 1,186 | $186.75 | $221.5K | 14,038 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-02-19 | 2019-02-21 | 202 | $187.27 | $37.8K | 13,836 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2019-02-19 | 2019-02-21 | 100 | $188.49 | $18.8K | 13,736 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2019-02-06 | 2019-02-08 | 25,026 | — | $0 | 25,026 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2019-02-06 | 2019-02-08 | 9,799 | — | $0 | 15,224 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2019-02-06 | 2019-02-08 | 3,516 | — | $0 | 5,425 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2018-10-08 | 2018-10-09 | 2,305 | $186.95 | $430.9K | 1,909 | SEC↗ |